Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jun 16;21(6):1014-7.
doi: 10.1021/bc1000802.

Poly(amidoamine) dendrimer based MRI contrast agents exhibiting enhanced relaxivities derived via metal preligation techniques

Affiliations

Poly(amidoamine) dendrimer based MRI contrast agents exhibiting enhanced relaxivities derived via metal preligation techniques

Kido Nwe et al. Bioconjug Chem. .

Abstract

This report presents the preparation and characterization of three [Gd-C-DOTA](-1)-dendrimer assemblies by way of analysis, NMRD spectroscopy, and photon correlation spectroscopy (PCS). The metal-ligand chelates were preformed in alcohol media prior to conjugation to generation 4, 5, and 6 PAMAM dendrimers. The dendrimer-based agents were purified by Sephadex G-25 column chromatography. The combustion analysis, SE-HPLC, and UV-vis data indicated chelate to dendrimer ratios of 28:1, 61:1 and 115:1, respectively. Molar relaxivity measured at pH 7.4, 22 degrees C, and 3 T (29.6, 49.8, and 89.1 mM(-1) s(-1)) indicated the viability of conjugates as MRI contrast agents. 1/T(1) NMRD profiles were measured at 23 degrees C and indicated that at 22 MHz the 1/T(1) reached a plateau at 60, 85, and 140 mM(-1) s(-1) for the generation 4, 5, and 6 dendrimer conjugates, respectively. The PCS data showed the respective sizes of 5.2, 6.5, and 7.8 nm for G-4, 5, and 6 conjugates.

PubMed Disclaimer

Figures

Figure 3
Figure 3
Molar relaxivity plots of G4-(C-DOTA-Gd)28 (■; 29.6 mM−1s−1), G5-(C-DOTA-Gd)61) (●; 49.8 mM−1s−1), G6-(C-DOTA-Gd)115) (▲; 89.1 mM−1s−1) and Magnevist (◆; 4.2 mM−1s−1).
Figure 4
Figure 4
1/T1 NMRD profiles of 1 mM solution of prohance (▲), Magnevist® (●), G4-(C-DOTA-Gd)28(−), G5-(C-DOTA-Gd)61(◆), G6-(C-DOTA-Gd)115(■), as a function of frequencies at 23°C.
Scheme 1
Scheme 1
Synthesis of dendrimer conjugates.

Similar articles

Cited by

References

    1. Caravan P. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem Soc Rev. 2006;35:512–523. - PubMed
    1. Villaraza AJL, Bumb A, Brechbiel MW. Macromolecules, Dendrimers, and Nanomaterials in Magnetic Resonance Imaging: The Interplay between Size, Function, and Pharmacokinetics. Chem Rev. 2010 in press. - PMC - PubMed
    1. Koyama Y, Talanov VS, Bernardo M, Hama Y, Regino CAS, Brechbiel MW, Choyke PL, Kobayashi H. A dendrimer-based nanosized contrast agent dual-labeled for magnetic resonance and optical fluorescence imaging to localize the sentinel lymph node in mice. J Magn Reson Imaging. 2007;25:866–871. - PubMed
    1. Lee CC, Gillies ER, Fox ME, Guillaudeu SJ, Frechet JMJ, Dy EE, Szoka FC. A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas. Proc Nat Acad Sci. 2006;103:16649–16654. - PMC - PubMed
    1. Gillies ER, Fréchet JMJ. Dendrimers and dendritic polymers in drug delivery. Drug Discov Today. 2005;10:35–43. - PubMed

Publication types

MeSH terms